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1. rntroduction 
Mucolipidosis I is a rare congenital disorder of 
complex carbohydrate metabolism, characterized 
clinically by coarse facial features, skeletal dysplasia, 
neurodegeneration, cherry-red macular spot, mental 
retardation, and early death [l-3] . An abnormal 
accumulation of sialic acid-containing compounds in 
cultured fibroblasts and leukocytes, and a profoundly 
diminished activity of an cw-neuraminidase (sialidase) in 
the former suggested a defect in the catabolism of 
sialoglycopeptides and/or gangliosides a  the meta- 
bolic basis of this disease [3,4] . In this communica- 
tion, we report on the excessive xcretion and the 
structure of urinary sialyl-oligosaccharides in apatient 
with mucolipidosis I. 
2. Materials and methods 
Sialyl-oligosaccharides were fractionated as 
described in previous papers [5,6] . Their structures 
were determined by methylation, periodate oxidation, 
hydrazinolysiq-nitrous deamination, and NMR spectro- 
scopy. The chemical investigations will be developed 
in a following article [7] . 
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3. Results 
As shown in fig. 1, more than 10 sialyl-oligosaccha- 
rides were identified in the urine of patient D. F. by 
paper chromatography of fractions eluted from a 
Dowex 1 X 2 column. The quantitation and carbohy- 
drate composition of the 10 major oligosaccharides 
are presented in table 1. When compared to the 
normal, the excretion of these compounds i  increased 
from about 80-800-fold. Figure 2 shows the complete 
structures of these sialyl-oligosaccharides, which 
closely resemble the glycan portions found in many 
glycoproteins. Invariably, the N-acetylneuraminic a id 
residues are located at a non-reducing terminus in 
either OL 2-6 or (Y 2-3 linkage to galactose. The 
reducing termini consist of N-acetylglucosamine, 
suggesting that each saccharide r sults from the action 
of an endo&N-acetylglucosaminidase on the parent 
sialoglycopeptide. 
4. Discussion 
The excessive urinary excretion of these sialyl- 
oligosaccharides must arise from the crneuraminidase 
deficiency in the patients tissues, which causes ablock 
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Fig.1. Paper chromatography of sialyl-oligosaccharides luted from Dowex 1 X 2 (200-400 mesh; acetate form) by a discontinuous 
gradient of pyridlne acetate (pH 5.4); 1 : 1 mM; 2 : 2 mM; 3 : 5 mM; 4 : 10 mM; 5 : 20 mM; 6 : 50 mM; 7 : 100 mM; 8 : 200 mM; 
9 : 500 mM. Paper Whatman No. 3. Solvent: ethyl acetate/pyridine/acetic acid/water (5:5: 1:3), developed during 5 days (A) or 
40 days (B). Chromatograms were stained with alanine oxalat reagent. 
Table 1 
Carbohydrate analysis of urinary sialyl-oligosaccharides 
Quantity (mgb) Molar ratios 
Mucolipidosis I Normal urine Gal Man GlcNAc AC Neu 
I 16 0.1-0.3 0.96 2 1.84 0.86 
II 185 0.2-0.3 1.12 2 1.94 0.92 
III 22 0.1-0.3 0.86 3 1.85 0.94 
IV 18 < 0.1 2.16 3 3.06 0.99 
V 32 0.1-0.5 1.84 3 2.76 0.84 
VI 38 < 0.1 1.91 3 2.84 2.04 
VII 11 < 0.1 1.84 3 2.96 1.96 
VIII 6 < 0.1 2.05 3 3.04 1.94 
IX 225 0.1-1.0 3.00 3 3.02 2.05 
X 112 ? 3.21 3 3.95 2.78 
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I 
II 
III 
Iv 
V 
VI 
VII 
VIII 
IX 
X 
a-Net&-(2 + 3)+-G&-(1 + 4)+GlCNAC-(1 + 2)-a-MZl-(1 + 3)-B-MII-(1 + 4)-GlCNk 
a-NeuAC-(2 + 6)-B-&l-(1 -+ 4)-~-GkNAtz-(1 + 2)-a*-(1 + 3)-B-Man-(1 + 4)-GlcMLc 
a-NeuAc-(2 + 6)-@-G&-(1 + 4)+GlcMlc-(1 + 2)-a-l&n-(1 + 3), 
,wan-(1 +4)-GlCNk 
a-&n-(1 + 6) 
a-Neu7ie(2 + 3)+Gal-(1 + 4)-f+GlCNk-(1 * 2)-s-Man-(1 + 3) 
)!3-!e(l +4)-GlCNAC 
B-Gal-(1 + 4)-f3_Gl~N&-(1 -, 2)-s-Man-(1 + 6) 
a-NeuRc-(2 + 6)-B--(1 + 4)-B-GlcNAc-(1 * 2)-s-Man-(1 + 3) 
\ 
,B+an-(1 +4)-GlCNAC 
@-Gal-(1 -c 4)-B-Glcm-(1 + 2)-a+fan-(1 + 6) 
a-Neu&c-(2 + 6)+-Gal-(1 + 4)+GlcNk-(1 + 2) 
\ a-Man-(l+ 3)-B-Man-(l+ 4)-Gl&@c 
a-NeuAC-(2 + 3)-B-Gal-(1 * 4)-f3_GlcM\c-(1 + 4)' 
a-NeuAc-(2 + 3)+3-&l-(1 + 4)-B-GlCNAC-(1 + 2)-s-Man-(1 + 3) 
\ 
B-Man-(1 -t 4)-GlcN&C 
a-Neuk-(2 + 3)-@-Gal-(1 -t 4)-f3_Gl~NA~-(l + 2)-a-Man-(1 + 6)' 
a-NfxAe(2 + 3)+Gal-(1 + 4)-B-GlCNk-(1 + 2)-s-Man-(1 + 3) 
)8-Mm-(1 +4)-GlCNAC 
a-N&&-(2 -+ 6)-fFC%d-(1 + 4)-f+Gl&@c-(1 + 2)-a-b&1-(1 + 6) 
a-NeuRc-(2 + 6)+Gal-(l+ 4)-B-GlcMlc-(1 + 2)-s-Man-(1 + 3) 
\ 
,wan-(1 +l)-Gl~ 
a-NeuAC-(2 + 6)-B-Gal-(1 + 4)-B-GlcNk-(1 + 2)-s-Mm-(1 -+ 6) 
a-NeuRc-(2 -c 3)-B-Gal-(1 + 4)-Bi;lcMLc-(1 + 2 or 4) 
\ 
,a+Ian-11'3 or 6) 
a-NeuRc-(2 + 6)+Gal-(1 + 4)-f3~kNAe(1 + 4 or 2) 'fM?ln-(1+4)-GlcNk 
a-NeuAC-(2 + 6)-BGal-(1 + 4)-B-GkNAcz-(1 + 2)-a-&n-(1 + 6 or 3) ' 
Fig.2. Structure of the 10 major sialyl-oligosaccharides isolated from MLP I urine. The structure of compound X here described 
results from preliminary investigations. 
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in the further catabolism of the chains by exoglycosi- 
dases. Urinary oligosaccharides of identical structures 
have been observed in three other genetic disorders 
with deficiency of an a-neuraminidase : mucolipidosis 
II and two ‘new’ types of mucolipidosis [6,8-lo] . In 
mucolipidosis II, the neuraminidase deficiency 
probably results from a defect in lysosomal enzyme 
localization involving many such hydrolases [ 1 l] . 
In mucolipidosis I and the other two forms of 
mucolipidosis, however, the neuraminidase deficiency 
is singular, suggesting the mutation of a gene which 
directly codes for the expression of a neuraminidase. 
At present, it cannot be decided whether the marked 
differences in phenotype between these latter types of 
mucolipidoses are due to allelic mutations at a single 
neuraminidase gene, to a deficiency of different 
neuraminidases, or to still another mechanism. 
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